Literature DB >> 16273289

Laughter therapy modulates the parameters of renin-angiotensin system in patients with type 2 diabetes.

Uddin Mohammad Nasir1, Shizuko Iwanaga, A H M Nurun Nabi, Osamu Urayama, Keiko Hayashi, Takashi Hayashi, Koichi Kawai, Afroza Sultana, Kazuo Murakami, Fumiaki Suzuki.   

Abstract

The effect of laughter therapy on the plasma levels of renin, angiotensinogen, and prorenin was investigated in patients with type 2 diabetes. In the diabetic patients, the mean plasma renin concentrations were 24.6+/-12.1 ng/ml/h in the first observation (at the beginning of laughter therapy), 8.2+/-3.4 ng/ml/h in the second observation (three months after the beginning of laughter therapy) and 7.7+/-1.7 ng/ml/h in the third observation (six months after the beginning of laughter therapy). The mean plasma angiotensinogen concentrations in the 1st, 2nd and 3rd observations were 0.19+/-0.08, 0.47+/-0.12, 0.42+/-0.14 microg/ml, respectively. The mean plasma prorenin concentrations in the 1st, 2nd and 3rd observations during the laughter therapy were 195.1+/-66.2, 193.4+/-88.2 and 170.7+/-52.5 pg/ml, respectively. Plasma renin concentrations were significantly decreased (p<0.05) by the therapy. Subnormal concentrations of plasma angiotensinogen were found in the 1st observation and increased significantly (p<0.05) to the normal range after the therapy. Plasma prorenin concentration only slightly changed during the laughter therapy. Other biochemical parameters remained unchanged during the laughter therapy. These results indicated that a long-term laughter therapy changed the plasma components of renin-angiotensin system in patients with diabetes. Thus, laughter therapy can be used as non-pharmacological treatment for the prevention of diabetic microvascular complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273289

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Establishing a novel assay system for measuring renin concentration using cost effective recombinant ovine angiotensinogen.

Authors:  Jobaida Akther; A H M Nurun Nabi; Satoshi Ohno; Takashi Yokogawa; Tsutomu Nakagawa; Fumiaki Suzuki; Akio Ebihara
Journal:  Heliyon       Date:  2019-04-04

2.  Laughter, humor and pain perception in children: a pilot study.

Authors:  Margaret Stuber; Sherry Dunay Hilber; Lisa Libman Mintzer; Marleen Castaneda; Dorie Glover; Lonnie Zeltzer
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.